We illustrate the usefulness of direct mutation detection for genetic counseling by showing its application to an extremely large mild haemophilia A pedigree (91 haemophiliacs) originating from the village of Aiani in Macedonia, northern Greece. The causative mutation has already been shown to be an A to T transversion in codon 280 of the FVIII gene which replaces Asn 280 (AAC) by Ile (ATC) and which creates a new Bam HI restriction site in exon 7. The latter permitted direct, rapid and reliable detection of the mutation in relevant family members. All major branches of the family were shown to share the mutation, and carrier status was diagnosed or excluded for 23 possible carriers. Other interesting characteristics of the Aiani haemophilic population are a slightly higher longevity and fecundity than that observed in the general population and a wide range of FVIII:C levels (5-25%) associated with the mutation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1365-2141.1995.tb08932.x | DOI Listing |
BioData Min
January 2025
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA.
Background: The mechanistic pathways that give rise to the extreme symptoms exhibited by rare disease patients are complex, heterogeneous, and difficult to discern. Understanding these mechanisms is critical for developing treatments that address the underlying causes of diseases rather than merely the presenting symptoms. Moreover, the same dysfunctional series of interrelated symptoms implicated in rare recessive diseases may also lead to milder and potentially preventable symptoms in carriers in the general population.
View Article and Find Full Text PDFSci Rep
January 2025
Department of Industrial Engineering and Management, Ming Chi University of Technology, New Taipei City, 243, Taiwan.
This study develops the you only look once segmentation (YOLOSeg), an end-to-end instance segmentation model, with applications to segment small particle defects embedded on a wafer die. YOLOSeg uses YOLOv5s as the basis and extends a UNet-like structure to form the segmentation head. YOLOSeg can predict not only bounding boxes of particle defects but also the corresponding bounding polygons.
View Article and Find Full Text PDFEnviron Res
January 2025
Department of Materials Science and Engineering, Xi'an University of Technology, Xi'an 710048, PR China; Shaanxi Province Key Laboratory of Corrosion and Protection, Xi'an University of Technology, Xi'an 710048, PR China. Electronic address:
Hexagonal boron nitride (h-BN) exhibits unique application potential in water purification due to its large specific surface area, high porosity, and chemical inertness. Designing adsorbents with highly active adsorption sites is one effective method to improve their adsorption capacities. In this study, porous h-BN aerogels containing multiple defect types (DP-BN) were synthesized by using salt templates.
View Article and Find Full Text PDFJ Anat
January 2025
Department of Anatomy and Regenerative Medicine, Tissue Engineering Research Group (TERG) Royal College of Surgeons Ireland (RCSI) University of Medicine and Health Sciences, Dublin, Ireland.
According to the World Health Organization (WHO) musculoskeletal conditions are a leading contributor to disability worldwide. This fact is often somewhat overlooked, since musculoskeletal conditions are less likely to be associated with mortality. Nonetheless, treatments, therapies and management of these conditions are extremely costly to national healthcare systems.
View Article and Find Full Text PDFRSC Chem Biol
January 2025
School of Chemistry, The University of Sydney Sydney NSW 2006 Australia
Targeted protein degraders, in the form of proteolysis targeting chimaeras (PROTACs) and molecular glues, leverage the ubiquitin-proteasome system to catalytically degrade specific target proteins of interest. Because such molecules can be extremely potent, they have attracted considerable attention as a therapeutic modality in recent years. However, while targeted degraders have great potential, they are likely to face many of the same challenges as more traditional small molecules when it comes to their development as therapeutics.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!